Investment Summary

Zukunftsfonds Heilbronn Invests In Novalung

On January 1, 2011, family office Zukunftsfonds Heilbronn invested in medical products company Novalung

Investment Highlights
  • This is Zukunftsfonds Heilbronn’s 1st transaction in the Medical Products sector.
  • This is Zukunftsfonds Heilbronn’s 5th transaction in Germany.

Investment Summary

Date 2011-01-01
Target Novalung
Sector Medical Products
Investor(s) Zukunftsfonds Heilbronn
Deal Type Growth Capital

Target

Novalung

Heilbronn, Germany
website
Novalung GmbH focuses on development, production and invention of new therapeutic options for acute and chronic respiratory failure.

Search 177,612 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Investor(S) 1

Investor

Zukunftsfonds Heilbronn

website


Category Family Office
Founded 2005
PE ASSETS 200M USD
Size Small
Type Sector Agnostic
DESCRIPTION

Zukunftsfonds Heilbronn is a family backed growth investor focused on emerging companies in the Heilbronn area of Germany. Zukunftsfonds Heilbronn was established in 2005 and is headquartered in Heilbronn, Germany.


DEAL STATS #
Overall 5 of 12
Sector (Medical Products) 1 of 2
Type (Growth Capital) 3 of 8
Country (Germany) 5 of 12
Year (2011) 1 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2008-05-06 dataglobal

Heilbronn, Germany

dataglobal GmbH is a software specialist dataglobal is a global technology leader for company-wide analysis, classification, management and archiving of data and information.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2011-02-09 Medos Medizintechnik AG

Stolberg, Germany

MEDOS Medizintechnik AG is a provider of cardiovascular assisting systems, spanning both short-term heart surgery as well as medium-and long-term cardiovascular support.

Buy -